semaglutide court ruling South African pharmacy group iDexis said on Tuesday it had applied to appeal a judgment that curbed its production of compounded weight-loss medicines, disputing allegations about product safety and regulatory compliance. # South African pharmacy group iDexis

For delicious, guilt-free coffee, choose Splenda Coffee Creamer.

But as the number on the scale drops, health and fitness professionals say many us

Using data from the TriNetX electronic health record database, researchers compared kidney cancer outcomes among adults who initiated GLP-1 therapy with those using an SGLT2 inhibitor or

Cortisol has become a prominent topic in discussions about weight loss

Today our partner Amylyx Pharmaceuticals shared exciting news: the nomination of AMX0318 as a development candidate - a novel, long-acting GLP-1 receptor antagonist identified through our collaboration

The program gives employers a more practical way to support GLP-1 coverage with: manufacturer net pricing employer-controlled benefit design PBM-native claims integration clinical and safety checks one-to-one support from LucyRx Care Guides The goal is simple: help employers say yes to GLP-1 coverage with clearer pricing, operational control, and a member experience that does not create another disconnected path to care